These cumulative changes ultimately may lead to altered systemic metabolism and adiposity in vivo, with impaired glucose tolerance and insulin sensitivity and increased adiposity observed in LL:AA mice over time. The gene discussed is INS; the disease is Impaired glucose tolerance.